Editors' ChoiceCancer

Addicted to Cancer

See allHide authors and affiliations

Science Translational Medicine  14 Apr 2010:
Vol. 2, Issue 27, pp. 27ec61
DOI: 10.1126/scitranslmed.3001147

Article Information

vol. 2 no. 27 27ec61

DOI: 
https://doi.org/10.1126/scitranslmed.3001147
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2010, American Association for the Advancement of Science

Author Information

  1. Alexei Morozov
  1. Medical Oncology Fellowship Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

Altmetric

Article usage

Article usage: April 2010 to April 2021

AbstractFullPdf
Apr 201002110
May 20100400
Jun 2010060
Jul 2010010
Aug 2010010
Sep 2010020
Oct 2010030
Nov 2010010
Jan 2011090
Feb 2011050
Mar 2011010
Apr 2011010
May 2011010
Jul 2011010
Oct 2011020
Nov 2011010
Mar 2012070
Apr 2012020
May 2012010
Jul 2012010
Aug 2012060
Feb 2013030
Mar 2013090
Apr 2013020
May 20130170
Jun 20130160
Jul 20130130
Aug 2013090
Sep 20130100
Oct 2013060
Nov 2013030
Dec 2013090
Jan 20140120
Feb 20140120
Mar 20140120
Apr 2014060
Oct 2014010
Dec 2014010
Jan 2015010
Mar 2015010
Apr 2015010
Oct 2015010
Apr 2016010
May 2016020
Jun 2016020
Jul 2016040
Aug 2016040
Sep 2016003
Oct 2016010
Jan 2017020
Feb 2017090
Mar 20170230
Apr 2017060
May 20170140
Jun 2017030
Jul 20170480
Aug 20170230
Sep 20170260
Oct 20170210
Nov 20170230
Dec 20170200
Jan 20180160
Feb 2018090
Mar 20180300
Apr 20180530
May 20180750
Jun 20180810
Jul 20180330
Aug 20180380
Sep 20180500
Oct 20180530
Nov 20180310
Dec 20180310
Jan 20190360
Feb 20190460
Mar 20190171
Apr 20190280
May 20190290
Jun 20190241
Jul 20190110
Aug 20190120
Sep 20190190
Oct 20190262
Nov 20190140
Dec 20190211
Jan 20200110
Feb 20200160
Mar 2020080
Apr 20200140
May 2020050
Jun 2020090
Jul 2020060
Aug 2020090
Sep 20200150
Oct 20200170
Nov 20200140
Dec 20200140
Jan 2021070
Feb 2021070
Mar 2021090
Apr 2021010

View Full Text

Article Tools

  • Email

  • Alerts
  • Citation tools

  • Addicted to Cancer

    By Alexei Morozov

    Science Translational Medicine : 27ec61

    While EGFR (ErbB1) and Her2 (ErbB2) have long been known as targets for cancer therapeutics, the third family member, ErbB3, now comes to the forefront in ovarian cancer.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article